Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

NSE/CORONA stock hub

NSE/CORONA has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NSE/CORONAis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

104.7B

National Stock Exchange of India

Market data

Live price

Current market quote for this ticker.

Current price

NSE/CORONA

In the news

Latest news · NSE/CORONA

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E45.1

P25 n/aP50 n/aP75 n/a

Trailing P/E61.1

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC27.8

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NSE/CORONA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

133

Groups with data

Currency

INR

Showing 133 of 133 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	4,500
Enterprise value	INR 104.8B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Last refreshed	2026-05-10
Market cap	INR 104.7B
Price	INR 1,712
Price currency	INR
Rev Per Employee	2,986,166.67x
Sic	2834
Symbol	nse/CORONA
Website	https://www.coronaremedies.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.64%
EV Earnings	61.17x
EV/EBIT	42.1x
EV/EBITDA	35.91x
EV/Sales	7.8x
Forward P/E	45.1x
P/B ratio	15.88x
P/E ratio	61.11x
P/S ratio	7.79x
PEG ratio	2x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	18.51%
EBITDA Margin	21.45%
Gross margin	80.79%
Gross Profit	INR 10.9B
Gross Profit Growth	38.97%
Gross Profit Growth Q	16.36%
Net Income	INR 1.7B
Net Income Growth	89.32%
Net Income Growth Q	-8.19%
Pretax Margin	17.06%
Profit Margin	12.75%
Profit Per Employee	INR 380,764
ROIC	27.81
Roic5y	16.64

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS Growth	89.35
EPS Growth Q	-8.16
Revenue Growth	32.46x
Revenue Growth Q	15.03x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 539.6M
Debt	INR 627.1M
Debt EBITDA	INR 0.21
Debt Equity	INR 0.1
Equity	INR 6.6B
Interest Coverage	32.95
Net Cash	INR -87.5M
Net Cash By Market Cap	INR -0.08
Net Debt EBITDA	INR 0.03
Net Debt Equity	INR 0.01
Tangible Book Value	INR 4.9B
Tangible Book Value Per Share	INR 80.35

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.03%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
50-day SMA	1,607.7
All Time High	1,790
All Time High Change	-4.34%
All Time High Date	2026-05-06
All Time Low	1,336.6
All Time Low Change	28.11%
All Time Low Date	2025-12-23
ATR	68.08
Beta1y	0.31
Ch YTD	23.64
High	1,760
High52	1,790
High52 Date	2026-05-06
High52ch	-4.34%
Low	1,679.9
Low52	1,336.6
Low52 Date	2025-12-23
Low52ch	28.11%
Ma50ch	6.51%
RSI	59.3
RSI Monthly	0
RSI Weekly	64.13
Sharpe ratio	1.43x
Sortino ratio	2.37
Total Return	0.03%
Tr YTD	23.64
Tr1m	12.93%
Tr1w	-1.06%
Tr3m	11.38%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 2.5B
Operating Income Growth	94.61
Operating Income Growth Q	23.41
Operating margin	18.51

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	6,174,051%
Shares Insiders	69%
Shares Institutions	6%
Shares Out	61,160,088
Shares Qo Q	-0.09%
Shares Yo Y	-0.03%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	27,939.15x
Bv Per Share	107.8
Ch1m	12.93
Ch1w	-1.06
Ch3m	11.38
Change	-1.76%
Change From Open	-2.71
Close	1,742.9
Days Gap	0.98
Depreciation Amortization	395,620,000
Dollar Volume	21,818,126.6
Earnings Date	2026-05-11
EBIT	INR 2.5B
EBITDA	INR 2.9B
EPS	INR 28.02
F Score	2
Fiscal Year End	March
Founded	2,004
Graham Number	260.69449
Graham Upside	-84.78
Income Tax	INR 579.5M
Is Primary Listing	1
Last Earnings Date	2026-02-02
Last Report Date	2025-12-31
Ma20	1,659
Ma20ch	3.21%
Next Earnings Date	2026-05-11
Open	1,760
Position In Range	40.45
Price Date	2026-05-08
Price EBITDA	INR 36.33
Ptbv Ratio	21.3
Relative Volume	0.46x
Revenue	13,437,750,000x
Tax By Revenue	4.31x
Tax Rate	25.27%
Volume	12,742

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does NSE/CORONA pay a dividend?

Capital-return profile for this ticker.

Ownership

Who owns NSE/CORONA?

Insider, institutional, and short-interest positioning.

Institutional ownership

+6.0%

Share of float held by funds and institutions

Insider ownership

+69.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.0%

Negative means the company is buying back shares.

Technical

NSE/CORONA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

59.3

Neutral momentum band

Price vs 200-day MA

n/a

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

1.43

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NSE/CORONA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current nse/CORONA stock rating?

nse/CORONA is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full nse/CORONA analysis?

The full report lives at /stocks/nse/CORONA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for nse/CORONA?

The latest report frames nse/CORONA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the nse/CORONA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.